In this study, we established various gemcitabine-resistant subclones of human pancreatic cancer cell lines, and investigated changes in gene expression associated with gemcitabine transport and metabolism, that is, hENT1, dCK, RRM1, and RRM2 mRNA, in the development of gemcitabine resistance. Here, RRM2 is linked to pancreatic neoplasm.